Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Long Term Extension Study of Diacerein 1% Ointment in EBS
NCT03389308Phase 2Completed
- Sponsor
- Castle Creek Biosciences
- Start
- Dec 2017
- Primary completion
- Apr 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of AC-203 in epidermolysis bullosa simplex (EBS), sponsored by Castle Creek Biosciences. Started Dec 2017; status: completed.
02
Drugs
AC-203
03
Conditions
epidermolysis bullosa simplex (EBS)
Beyond the preview
Go deeper on NCT03389308.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03389308.